Top Markets
Coin of the day
Cell MedX Corp. Cell MedX Corp.

Cell MedX Corp.

CMXC
Rang in aandelen #30404
Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing,... Cell MedX Corp. is a biotechnology firm dedicated to identifying, developing, and marketing both therapeutic and non-therapeutic solutions aimed at individuals suffering from conditions such as diabetes, Parkinson's disease, hypertension, neuropathy, and various kidney-related ailments. The company's offerings include the eBalance Pro System, designed for clinical application by medical professionals, and the eBalance Home System, intended for personal use to promote general well-being and alleviate pain. Both systems are managed by the eBalance Console, a central control unit featuring three distinct pre-programmed microcurrent algorithms: wellness, pain management, and a dual mode. Originally established in 2010 as Sports Asylum, Inc., the company adopted its current name, Cell MedX Corp., in September 2014. Its operations are headquartered in Carson City, Nevada.
Aandeelprijs
$0.41
Laatst gesynchroniseerd: 2024-12-24
Marktkapitalisatie
$16.96M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Cell MedX Corp. (CMXC)

Categorie

P/B-ratio voor Cell MedX Corp. (CMXC)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Cell MedX Corp. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Cell MedX Corp. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US